Brief: Venus Concept Receives FDA 510(K) Clearance Of Venus Blissmax For Non-Invasive Lipolysis Of The Abdomen And Flanks, Cellulite Reduction And Muscle Conditioning

Venus Concept

18/01/2022 21:08

Jan 18 (Reuters) - Venus Concept Inc  VERO.O :
    * VENUS CONCEPT RECEIVES FDA 510(K) CLEARANCE OF VENUS
BLISSMAX
FOR NON-INVASIVE LIPOLYSIS OF THE ABDOMEN AND FLANKS, CELLULITE
REDUCTION AND MUSCLE CONDITIONING
    * VENUS CONCEPT INC - LOOK FORWARD TO INITIATING A LIMITED
COMMERCIAL LAUNCH FOR BLISSMAX IN U.S. BY END OF Q1 OF 2022

Source text for Eikon:  ID:nGNX1fkkTF 
Further company coverage:  VERO.O 

 ((Reuters.Briefs@thomsonreuters.com;))